SavedAdd your journal

Journals / Kafkas Journal of Medical Sciences / 2026 / Cilt: 8 Sayı: 2

The Incidence of Adenomyosis in Histerectomy Cases

Histerektomi Olgularında Adenomyozis İnsidansı

Yakup Baykuş(Kafkas Üniversitesi Tıp Fakültesi, Kadın Hastalıkları ve Doğum Anabilim Dalı)
Rulin Deniz(Kafkas Üniversitesi Tıp Fakültesi, Kadın Hastalıkları ve Doğum Anabilim Dalı)
Ebru Çelik Kavak(Fırat Üniversitesi Tıp Fakültesi, Kadın Hastalıkları ve Doğum Anabilim Dalı)
Hasan Çılgın(Kafkas Üniversitesi Tıp Fakültesi, Kadın Hastalıkları ve Doğum Anabilim Dalı)
Haldun Arpacı(Kafkas Üniversitesi Tıp Fakültesi, Kadın Hastalıkları ve Doğum Anabilim Dalı)
Nazan Ardıç(Kafkas Üniversitesi Tıp Fakültesi, Kadın Hastalıkları ve Doğum Anabilim Dalı)
Ömür Öztürk(Çanakkale Onsekiz Mart Üniversitesi Tıp Fakültesi, Anesteziyoloji ve Reanimasyon Anabilim Dalı)
Pages
128–132
Publication Date
2018-08-01
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Especially in treatment resistant menometroragia cases adenomyozis should be thought in aethiology

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: To investigate the incidence of adenomyosis in histerectomy cases.
📊
Key Findings & Data:Material and Method: The incidence of adenomyosis was evaluated in cases who had undergone hysterectomy of any cause between January 2005-December 2015.
💡
Conclusion & Impact:Especially in treatment resistant menometroragia cases adenomyozis should be thought in aethiology
🔬Design:Araştırma Makalesi
📍Scope:2005 Verileri
⚙️Variables:histerektomi · adenomyozis · insidans

Abstract

Aim: To investigate the incidence of adenomyosis in histerectomy cases. Material and Method: The incidence of adenomyosis was evaluated in cases who had undergone hysterectomy of any cause between January 2005-December 2015. Results: In 58% of 205 cases with vaginal hysterectomy the final histopathological evalaution was adenomyosis. The indication for operations of these cases was: pelvic organ prolapsus (n: 117, 57%), endometrial hyperplasia (n: 40, 19.5%), servical displasies (n: 15, 7.3%), postmenoposal bleeding (n: 11, 5.3%), treatment resistant menometroragia (n: 10, 4.9%), leimyoma (n: 9, 4.4%), endometrial polip (n: 2, 1%) and mole hydatiform (n: 1, 0.5%). An additional operation was performed together with vaginal hysterectomy in 64.8% (n: 133) of the cases. The additional operations were sistorectosel operation (n: 46, 34.5%), rektosel operation (n: 26, 19.5%), sistosel operation (n: 22 16.5%), sacrospinosis fixation (n: 21, 15.7%) and transobturatuar tape. Conclusion: Preoperative adenomyosis can be diagnosed more frequently between the ages 40–50 years. Especially in treatment resistant menometroragia cases adenomyozis should be thought in aethiology

Özet

Amaç: Histerektomi yapılan olgularda adenomyozis insidansının araştırılması. Materyal ve Metot: Ocak 2005-Aralık 2015 tarihleri arasında değişik nedenlerle vajinal histerektomi yapılan olgularda adenomyozis insidansı araştırıldı. Bulgular: Vajinal histerektomi yapılan 205 olgunun 58’inde (%28,3) final histopatolojide adenomyozis tespit edildi. Bu olguların operasyon endikasyonları; pelvik organ prolapsusu (n: 117, %57), endometrial hiperplaziler (n: 40, %19,5), servikal displaziler (n: 15, %7,3), postmenopozal kanama (n: 11, %5,3), tedaviye dirençli menometroraji (n: 10, %4,9), leiomyomlar (n: 9, %4,4), endometriyal polip (n: 2, %1) ve mol hidatiform (n: 1, %0,5) idi. Bu olguların %64,8’ine (n: 133) vajinal histerektomi ile beraber ek operasyon uygulandı. Uygulanan ek operasyonlar; sistorektosel operasyonu (n: 46, %34,5), rektosel operasyonu (n: 26, %19,5), sistosel operasyonu (n: 22 %16,5), sakrospinöz fiksasyon (n: 21, %15,7) ve trans obturatuar tape uygulamasıydı. Sonuç: Preoperatif adenomyozis tanısı, olguların bir bütün halinde değerlendirilmesi halinde özellikle 40–50 yaş grubunda daha sık konulabilir. Özellikle tedaviye dirençli menometroraji olgularında etyolojide adenomyozis olabileceği akılda tutulmalıdır.

🔖

Cite This Article

Baykuş, Y., Deniz, R., Kavak, E. Ç., Çılgın, H., Arpacı, H., Ardıç, N., Öztürk, Ö. (2018). The Incidence of Adenomyosis in Histerectomy Cases. Kafkas Journal of Medical Sciences, Cilt: 8 Sayı: 2, 128–132. https://doi.org/10.5505/kjms.2018.38159

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (21)

  1. Pernoll ML. Obstetrik ve Jinekoloji El Kitabı. Ayhan A (Çeviren) 10. baskı, Ankara: Palme, 2002:755–67
  2. Hunter WC, Smith LL, Reiner WC. Uterine adenomyosis; incidence, symptoms and pathology in 1856 hysterectomies. Am J Obstet Gynecol 1947;53(4):663–8
  3. Bird CC, McElin TW, Manalo-Estrella P. The elusive adenomyosis of the uterus-revisited. Am J Obstet Gynecol 1972;112(5):583–93
  4. Israel SL, Woutersz TB. Adenomyosis: a neglected diagnosis. Obstet. Gynecol 1959;14(2):168–73
  5. Kavak SB. Histerektomi materyallerinde adenomyozis sıklığının araştırılması. Fırat Tıp Dergisi 2009;14(4):247–9
  6. Kunz G, Beil D, Huppert P, M. Noe S. Kissler G. Leyendecker. Adenomyosis in endometriosis prevalence and impact on fertility. Evidence from magnetic resonance imaging. Hum Reprod 2005;20(8):2309–16
  7. Serin İS, Özçelik B, Öztürk F, Yılmaz MO, Başbuğ M, Ökten T. Adenomyosis uteri: clinicopathologic analyses of 460 cases. Gynecol Obstet Reprod Med 2002;8(1):34–6
  8. Fong YF, Singh K. Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system. Contraception 1999;60(3):173–5
  9. Sheng J, Zhang WY, Zhang JP, Lu D. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis. Contraception 2009;79(3):189–93
  10. Igarashi M, Abe Y, Fukuda M, Ando A, Miyasaka M, Yoshida M et al. Novel conservative medical therapy for uterine adenomyosis with a danazol-loaded intrauterine device. Fertil Steril 2000;74(2):412–3
  11. Lin J, Sun C, Zheng H. Gonadotropin-releasing hormone agonists and laparoscopy in the treatment of adenomyosis and infertility. Chin Med J 2000;113(5):442–5
  12. Reinhold C, McCharty S, Bret PM, Mehio A, Atri M, Zakarian R et al. Diffuse adenomyosis: comparison of endovaginal US and MR imaging with histopathologic correlation. Radiology 1996;199:151–8
  13. Shaikh H, Khan KS. Adenomyosis in pakistani women: four year experience at the Aga Khan University Medical Centre, Karachi. J Clin Pathol 1990;43(10):817–9
  14. Vercellini P, Parazzini F, Oldani S, Panazza S, Bramante T, Crosignani PG. Adenomyosis at hysterectomy: a study on frequency distribution and patient characteristics. Hum Reprod 1995;10(5):1160–2
  15. Parazzini F, Vercellini P, Panazza LC, Chatenoud L, Oldani S, Crosignani PG. Risk factors for adenomyosis. Hum Reprod 1997;12(6), 1275–9
  16. Emge LA. The elusive adenomyosis of the uterus. Am J Obstet Gynecol 1962;83:1541–63
  17. Azziz R. Adenomyosis in pregnancy. J. Reprod Med 1986;31(4):224–7
  18. Matalliotakis IM, Katsikis IK, Panidis DK. Adenomyosis: what is the impact on fertility? Curr Opin Obstet Gynecol 2005;17(3):261–4
  19. Takahashi K, Nagata H, Kitao M. Clinical usefulness of determination of estradiol level in the menstrual blood for patients with endometriosis. Nippon Sanka Fujinka Gakkai Zasshi 1989;41(11), 1849–50
  20. Lee NC, Dicker RC, Rubin GL, Ory HW. Confirmation of the preoperative diagnosis for hysterectomy. Am J Obstet Gynecol 1984;150(3):283–7
  21. Kim MH. Dysfunctional uterine bleeding. In: Copeland IJ editor. Textbook of Gynecology 15t ed. WB Saunders Comp 1993;391–7.